Somaxon Pharmaceuticals, Inc. (SOMX) - NASDAQ
SOMX is defunct.
  • Asif Suria | Send Message 17 Dec 2012

    New Post: Merger Arbitrage Mondays $IN $HLYS $TNS $SOMX $GILD
      • Asif Suria | Send Message 11 Dec 2012

        Pernix Therapeutics Announces Agreement to Acquire Somaxon Pharmaceuticals, Inc. $SOMX $PTX
          • freefdawatchlist | Send Message 10 May 2012

            Earnings b4 market open: $ACCO $ALT $AG, $ADY $MT $ATPAQ $BIOD $CSIQ $DYN $GNVC $INO, $NHI $PDCE $RGDX $SOMX $VITC $SNE $SLF $TGX $VITC $WIN
              • Kinetic Investments | Send Message 19 Dec 2011

                $SOMX - Somaxon to explore strategic options, cut jobs. A Biotech Failure -
                  • talia1015 | Send Message 24 Jan 2011

                    Selling looks to be over on SOMX. Starting new long position today.
                      • djn21 | Send Message 12 Nov 2010

                        Added to SOMX holdings today at 3.21 on relative strength. Stop around 3.10, which is 50% Fib pullback of breakout, 2.60 - 3.60
                          • Robert J. Hall | Send Message 5 Nov 2010

                            $AMD, $NG, $F, $SOMX Market down slightly, but these are up strongly.
                              • djn21 | Send Message 5 Nov 2010

                                Looks like after a steep decline SOMX maybe have put in a doji bottom yesterday and maybe starting its climb today.
                                  • Bespoke Investment Group | Send Message 2 Sep 2010

                                    Best performing Russell 3,000 stocks year to date: $WNC $SOMX $AERG.OB $IDT $APKT $NFLX $OPEN $LVS $PAR $$
                                      • Bespoke Investment Group | Send Message 28 Jun 2010

                                        Reaching the Halfway Mark: $$ $NFLX $WNC $SOMX $CPE $GRNB $AERG.OB
                                          Company Description
                                          We are a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. We submitted our NDA for Silenor®... More
                                          Sector: Healthcare
                                          Industry: Drug Manufacturers - Other
                                          Country: United States